Serda RE - Search Results

1

Monitoring Therapeutic Responses to Silicified Cancer Cell Immunotherapy Using PET/MRI in a Mouse Model of Disseminated Ovarian Cancer.

Taylor EN, Wilson CM, Franco S, De May H, Medina LY, Yang Y, Flores EB, Bartee E, Selwyn RG, Serda RE. Taylor EN, et al. Among authors: serda re. Int J Mol Sci. 2022 Sep 10;23(18):10525. doi: 10.3390/ijms231810525. Int J Mol Sci. 2022. PMID: 36142437 Free PMC article.

2

Biomimetic Rebuilding of Multifunctional Red Blood Cells: Modular Design Using Functional Components.

Guo J, Agola JO, Serda R, Franco S, Lei Q, Wang L, Minster J, Croissant JG, Butler KS, Zhu W, Brinker CJ. Guo J, et al. ACS Nano. 2020 Jul 28;14(7):7847-7859. doi: 10.1021/acsnano.9b08714. Epub 2020 May 11. ACS Nano. 2020. PMID: 32391687

3

Direct Transfer of Mesoporous Silica Nanoparticles between Macrophages and Cancer Cells.

Franco S, Noureddine A, Guo J, Keth J, Paffett ML, Brinker CJ, Serda RE. Franco S, et al. Among authors: serda re. Cancers (Basel). 2020 Oct 9;12(10):2892. doi: 10.3390/cancers12102892. Cancers (Basel). 2020. PMID: 33050177 Free PMC article.

4

Cancer vaccines from cryogenically silicified tumour cells functionalized with pathogen-associated molecular patterns.

Guo J, De May H, Franco S, Noureddine A, Tang L, Brinker CJ, Kusewitt DF, Adams SF, Serda RE. Guo J, et al. Among authors: serda re. Nat Biomed Eng. 2022 Jan;6(1):19-31. doi: 10.1038/s41551-021-00795-w. Epub 2021 Nov 1. Nat Biomed Eng. 2022. PMID: 34725505 Free PMC article.

5

Endolysosomal Mesoporous Silica Nanoparticle Trafficking along Microtubular Highways.

Noureddine A, Paffett ML, Franco S, Chan AE, Pallikkuth S, Lidke K, Serda RE. Noureddine A, et al. Among authors: serda re. Pharmaceutics. 2021 Dec 27;14(1):56. doi: 10.3390/pharmaceutics14010056. Pharmaceutics. 2021. PMID: 35056951 Free PMC article.

6

Specific Tumor Localization of Immunogenic Lipid-Coated Mesoporous Silica Nanoparticles following Intraperitoneal Administration in a Mouse Model of Serous Epithelial Ovarian Cancer.

Noureddine A, Marwedel B, Tang L, Medina LY, Serda RE. Noureddine A, et al. Among authors: serda re. Cancers (Basel). 2023 Sep 19;15(18):4626. doi: 10.3390/cancers15184626. Cancers (Basel). 2023. PMID: 37760595 Free PMC article.

7

TLR Agonist Nano Immune Therapy Clears Peritoneal and Systemic Ovarian Cancer.

Marwedel B, De May H, Anderson L, Medina LY, Kennedy E, Flores E, O'Rourke J, Olewine M, Lagutina I, Fitzpatrick L, Shultz F, Kusewitt DF, Bartee E, Adams S, Noureddine A, Serda RE. Marwedel B, et al. Among authors: serda re. Adv Healthc Mater. 2024 Oct 31:e2402966. doi: 10.1002/adhm.202402966. Online ahead of print. Adv Healthc Mater. 2024. PMID: 39478634

8

Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging.

Serda RE, Adolphi NL, Bisoffi M, Sillerud LO. Serda RE, et al. Mol Imaging. 2007 Jul-Aug;6(4):277-88. Mol Imaging. 2007. PMID: 17711783

9

Multimodal imaging of the tumor microenvironment and biological responses to immune therapy.

Saucedo AM, De La Cerda J, Suami H, Serda RE. Saucedo AM, et al. Among authors: serda re. Biomed Microdevices. 2018 Dec 3;20(4):105. doi: 10.1007/s10544-018-0347-8. Biomed Microdevices. 2018. PMID: 30535532 Free PMC article.

10

Biotransport kinetics and intratumoral biodistribution of malonodiserinolamide-derivatized [60]fullerene in a murine model of breast adenocarcinoma.

Lapin NA, Vergara LA, Mackeyev Y, Newton JM, Dilliard SA, Wilson LJ, Curley SA, Serda RE. Lapin NA, et al. Among authors: serda re. Int J Nanomedicine. 2017 Nov 15;12:8289-8307. doi: 10.2147/IJN.S138641. eCollection 2017. Int J Nanomedicine. 2017. PMID: 29180866 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters